Esenam Dankwa
Psychiatric/Mental Health · Statesville, NCNPI 1093428013
Payments from drug & device makers
Across 112 payments — averaging $18.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$619
- AbbVie$360
- Otsuka America Pharmaceutical, Inc.$205
- Neurocrine Biosciences, Inc.$131
- E.r. Squibb & Sons, L.L.C.$102
- Novo Nordisk$101
- plus $508 from 11 others
What the payments were for
- Food & beverage$1,91594%
- Education$1116%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 37 | $619 |
| AbbVie | 28 | $360 |
| Otsuka America Pharmaceutical, Inc. | 11 | $205 |
| Neurocrine Biosciences, Inc. | 5 | $131 |
| E.r. Squibb & Sons, L.L.C. | 6 | $102 |
| Novo Nordisk | 1 | $101 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $85 |
| Lundbeck LLC | 4 | $84 |
| Alkermes, Inc. | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| Supernus Pharmaceuticals, Inc. | 2 | $42 |
| Vanda Pharmaceuticals Inc. | 2 | $40 |
| Johnson & Johnson | 2 | $35 |
| Luye Pharma (USA) Ltd. | 1 | $26 |
| Idorsia Pharmaceuticals US Inc | 1 | $23 |
| Almatica Pharma LLC | 1 | $22 |
How this compares
$2,027 in reported general payments places this provider in the 75th percentile of 947 psychiatric/mental health providers in North Carolina.
See all psychiatric/mental health providers in North Carolina →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 27 | $207,625 |
| AustedoDeutetrabenazine | 15 | $145,227 |
| RexultiBrexpiprazole | 67 | $114,080 |
| Invega SustennaPaliperidone Palmitate | 24 | $75,208 |
| VraylarCariprazine Hcl | 32 | $48,315 |
| VyvanseLisdexamfetamine Dimesylate | 24 | $9,576 |
| QuviviqDaridorexant Hcl | 17 | $8,104 |
| Lurasidone Hcl | 26 | $6,746 |
| Aripiprazole | 143 | $6,504 |
| TrintellixVortioxetine Hydrobromide | 12 | $5,632 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 43 | $5,232 |
| Buspirone Hcl | 254 | $3,750 |
| Quetiapine Fumarate | 188 | $3,511 |
| Vilazodone Hcl | 28 | $3,335 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 28 | $2,643 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $131 | $207,62527 claims |
| Teva Pharmaceuticals USA, Inc.Austedo | $619 | $145,22715 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $205 | $114,08067 claims |
| Johnson & JohnsonInvega Sustenna | $35 | $75,20824 claims |
| AbbVieVraylar | $360 | $48,31532 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse, Trintellix | $50 | $15,20836 claims |
| Idorsia Pharmaceuticals US IncQuviviq | $23 | $8,10417 claims |
| Almatica Pharma LLCSertraline Hcl | $22 | $2,353214 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 947 psychiatric/mental health providers in North Carolina.
Other psychiatric/mental health in Statesville
- Karen OckenholtStatesville$19K
- Desiree MatthewsCharlotte$807K
- Benedetto PalomboCharlotte$671K
- Clarence RunnelsCreedmoor$339K
- Lisa SuddrethGastonia$111K
- April NandigamGreensboro$88K
- Hannah NealeyFuquay Varina$75K
- Jessica StoneRocky Mount$63K
- Deborah GranickRaleigh$28K
- Ronald PattersonFayetteville$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.